![Ryan Daws](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Daws
Director of Finance/CFO at
ENGENE THERAPEUTICS INC.
Net worth: - $ as of 2026-05-30
Profile
Ryan Daws is currently Chief Financial Officer at enGene Therapeutics, Inc. since 2023.
Former roles include CFO & Head-Business Development at Obsidian Therapeutics, Inc. from 2019 to 2023; Managing Director-Healthcare Investment Banking at Robert W.
Baird & Co., Inc. from 2017 to 2019; Chief Financial Officer at Concert Pharmaceuticals, Inc. from 2014 to 2017; Director at Stifel, Nicolaus & Co., Inc. from 2010 to 2013; Director at Cowen & Co. LLC from 2000 to 2009; and Principal at Aptiv Services US LLC.
Education includes undergraduate studies at the University of South Carolina and an MBA from Darla Moore School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-04-23 | 0 ( -.--% ) | - $ | 2026-05-30 |
Ryan Daws active positions
| Companies | Position | Start |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Director of Finance/CFO | 2023-11-26 |
Former positions of Ryan Daws
| Companies | Position | End |
|---|---|---|
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Director of Finance/CFO | 2023-10-31 |
Robert W. Baird & Co., Inc.
 Robert W. Baird & Co., Inc. Investment ManagersFinance Provides financial advisory, wealth, asset management and investment banking services | Corporate Officer/Principal | 2019-02-28 |
| CONCERT PHARMACEUTICALS, INC. | Director of Finance/CFO | 2017-06-14 |
Stifel, Nicolaus & Co., Inc.
 Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2013-05-31 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Director/Board Member | 2009-12-30 |
Training of Ryan Daws
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
90
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Concert Pharmaceuticals, Inc.
 Concert Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops novel medicines | Health Technology |
Stifel, Nicolaus & Co., Inc.
Stifel, Nicolaus & Co., Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Aptiv Services US LLC
 Aptiv Services US LLC Auto Parts: OEMProducer Manufacturing Manufactures automotive components | Producer Manufacturing |
University of South Carolina
 University of South Carolina Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Robert W. Baird & Co., Inc.
Robert W. Baird & Co., Inc. Investment ManagersFinance Provides financial advisory, wealth, asset management and investment banking services | Finance |
Darla Moore School of Business
 Darla Moore School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
- Stock Market
- Insiders
- Ryan Daws
